Albuterol brand names

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Albuterol Brand Names: Key Inhaler and Nebulizer Products

Common Albuterol Brand Names in the United States

Albuterol, a widely used bronchodilator for asthma and other respiratory conditions, is available under several brand names in the United States. The most recognized brands for albuterol metered-dose inhalers (MDIs) include Ventolin HFA, Proventil HFA, and ProAir HFA. These products are all racemic mixtures, meaning they contain both the (R)- and (S)-enantiomers of albuterol in equal parts 37.

Levalbuterol: The (R)-Enantiomer Brand

Levalbuterol is the purified (R)-enantiomer of albuterol and is marketed under the brand name Xopenex. Xopenex is available as both an inhalation solution for nebulizers and as an HFA inhaler. It is distinct from the racemic albuterol products and is sometimes promoted for its potential clinical advantages, although evidence for significant superiority remains inconclusive 167.

Albuterol Nebulizer Solutions and Device Brands

For nebulized albuterol therapy, especially in hospital settings, several large-volume nebulizer brands are used to deliver the medication. These include AirLife Misty Finity, Flo-Mist, Heart, and Hope. These devices are designed to provide continuous albuterol delivery, and studies show that their performance is generally similar, especially during the first several hours of use .

International and Generic Albuterol Brands

Outside the United States, and particularly in places like Mexico, additional albuterol brands are available, such as Sacrusyt, Assal, Xeneric-S, and Victory. These products may differ in their pharmaceutical performance compared to US brands, and consumers should be aware of possible variations in effectiveness . Additionally, some albuterol products may be marketed without a proprietary (brand) name, which does not necessarily mean they are generic equivalents to branded products like Ventolin HFA or Proventil HFA .

Conclusion

In summary, the main brand names for albuterol inhalers in the US are Ventolin HFA, Proventil HFA, and ProAir HFA, while levalbuterol is marketed as Xopenex. Nebulized albuterol is delivered using various device brands, and international markets offer additional brand options. It is important for patients and providers to recognize these brand names and understand that product performance may vary, especially with non-US or unbranded products 1234567.

Sources and full results

Most relevant research papers on this topic

Which Form of Albuterol for Acute Asthma in Children

Levalbuterol, the (R)-enantiomer, shows advantages over racemic albuterol for acute asthma in children.

2004·

0citations

·R. Dershewitz

A Comparison of Pharmaceutical Product Performance of Albuterol Inhalers Available in the United States and Those Obtained in a Mexican Border Town

Pharmacological variability exists among albuterol inhalers purchased in Mexico, highlighting potential differences in product performance compared to US-manufactured products.

2015·

6citations

·Meira Nocella et al.

Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics

Decreasing the interval between actuations of albuterol HFA from 60 to 30 and 15 seconds does not affect ProAir and Ventolin aerosol characteristics, but a 10-s delay significantly reduces fine-particle mass.

2017·

3citations

·A. Berlinski et al.

In-vitro comparison of 4 large-volume nebulizers in 8 hours of continuous nebulization.

Misty Finity and Hope nebulizers had more consistent solution output, while all tested nebulizers performed similarly during the first 5 hours of continuous nebulization.

In Vitro Study

2010·

6citations

·A. Berlinski et al.

The absence of a trade name does not equal a generic drug

The absence of a trade name does not necessarily equal a generic drug, and therapeutically equivalent products may not be interchangeable.

2005·

3citations

·Rn Linda Wisniewski et al.

Is There Any Advantage to Using Levalbuterol in the Treatment of Asthma?

Levalbuterol's therapeutic advantage over racemic albuterol in treating acute asthma symptoms remains inconclusive, and its cost is significantly higher than racemic albuterol, making it unjustifiable for routine use.

2004·

4citations

·M. Weinberger

Levalbuterol in the Treatment of Patients With Asthma and Chronic Obstructive Lung Disease

Levalbuterol provides greater bronchodilation than racemic albuterol, potentially improving clinical outcomes in patients with asthma and other obstructive airway diseases.

2004·

14citations

·G. D'Alonzo

Albuterol-Budesonide Pressurized Metered Dose Inhaler in Patients With Mild-to-Moderate Asthma

The albuterol-budesonide combination pressurized metered-dose inhaler effectively improves lung function and is well-tolerated by patients with mild-to-moderate asthma, supporting its use as a novel rescue therapy.

RCTLarge Human Trial

2023·

5citations

·B. Chipps et al.

Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy

Short-term treatment with extended-release albuterol may increase lean body mass, decrease fat mass, and improve functional measures in boys with dystrophinopathies, but muscle strength changes were not observed in this study.

RCT

2008·

51citations

·C. L. Skura et al.

Impact of Copayment Changes on Children's Albuterol Inhaler Use and Costs after the Clean Air Act Chlorofluorocarbon Ban

Increased copayments for brand-name CFC-free albuterol after the CFC ban did not decrease children's albuterol use but led to a modest increase in out-of-pocket costs.

Observational Study

2016·

9citations

·A. Galbraith et al.

Try another search

pharmacological treatment of intrusive thoughts

quantum mechanics and time travel

angiotensin-converting enzyme inhibitors mechanism of action

artificial intelligence in search engines

sickle cell disease gene therapy

cancer support organizations effectiveness